Grimm S - Search Results

1

The value of maintaining cognition in patients with mild cognitive impairment: The innovation headroom and potential cost-effectiveness of roflumilast.

Handels R, Grimm S, Blokland A, Possemis N, Ramakers I, Sambeth A, Verhey F, Vos S, Joore M, Prickaerts J, Jönsson L. Handels R, et al. Among authors: grimm s. Alzheimers Dement. 2023 Aug;19(8):3458-3471. doi: 10.1002/alz.13001. Epub 2023 Feb 18. Alzheimers Dement. 2023. PMID: 36808801

2

Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis.

Westwood M, Ramaekers B, Lang S, Grimm S, Deshpande S, de Kock S, Armstrong N, Joore M, Kleijnen J. Westwood M, et al. Among authors: grimm s. Health Technol Assess. 2018 Aug;22(44):1-264. doi: 10.3310/hta22440. Health Technol Assess. 2018. PMID: 30165935 Free PMC article. Review.

3

Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Grimm SE, Armstrong N, Ramaekers BLT, Pouwels X, Lang S, Petersohn S, Riemsma R, Worthy G, Stirk L, Ross J, Kleijnen J, Joore MA. Grimm SE, et al. Pharmacoeconomics. 2019 May;37(5):655-667. doi: 10.1007/s40273-018-0723-5. Pharmacoeconomics. 2019. PMID: 30293207 Review.

4

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Ramaekers BLT, Riemsma R, Grimm S, Fayter D, Deshpande S, Armstrong N, Witlox W, Pouwels X, Duffy S, Worthy G, Kleijnen J, Joore MA. Ramaekers BLT, et al. Among authors: grimm s. Pharmacoeconomics. 2019 Jul;37(7):887-894. doi: 10.1007/s40273-018-0738-y. Pharmacoeconomics. 2019. PMID: 30426463 Free PMC article.

5

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Grimm SE, Fayter D, Ramaekers BLT, Petersohn S, Riemsma R, Armstrong N, Pouwels X, Witlox W, Noake C, Worthy G, Kleijnen J, Joore MA. Grimm SE, et al. Pharmacoeconomics. 2019 Oct;37(10):1195-1207. doi: 10.1007/s40273-019-00792-7. Pharmacoeconomics. 2019. PMID: 30895564 Free PMC article. Review.

6

Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models.

Grimm SE, Pouwels X, Ramaekers BLT, Wijnen B, Knies S, Grutters J, Joore MA. Grimm SE, et al. Pharmacoeconomics. 2020 Feb;38(2):205-216. doi: 10.1007/s40273-019-00855-9. Pharmacoeconomics. 2020. PMID: 31709496 Free PMC article.

7

Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Witlox WJA, van Asselt ADI, Wolff R, Armstrong N, Worthy G, Chalker A, Buksnys T, Stirk L, Kleijnen J, Joore MA, Grimm SE. Witlox WJA, et al. Pharmacoeconomics. 2020 Apr;38(4):317-324. doi: 10.1007/s40273-019-00870-w. Pharmacoeconomics. 2020. PMID: 31814080 Free PMC article. Review.

8

Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Wijnen B, Armstrong N, Ramaekers B, Witlox W, Westwood M, Fayter D, Ryder S, Buksnys T, Worthy G, Misso K, Grimm S, Kleijnen J, Joore M. Wijnen B, et al. Among authors: grimm s. Pharmacoeconomics. 2020 Oct;38(10):1043-1053. doi: 10.1007/s40273-020-00932-4. Pharmacoeconomics. 2020. PMID: 32514751 Review.

9

Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis.

Sankatsing VDV, Juraniec K, Grimm SE, Joore MA, Pijnappel RM, de Koning HJ, van Ravesteyn NT. Sankatsing VDV, et al. Radiology. 2020 Oct;297(1):40-48. doi: 10.1148/radiol.2020192505. Epub 2020 Aug 4. Radiology. 2020. PMID: 32749212 Free PMC article.

10

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Witlox WJA, Grimm SE, Riemsma R, Armstrong N, Ryder S, Duffy S, Carrera VH, Posadzki P, Worthy G, Pouwels XGLV, Ramaekers BLT, Kleijnen J, Joore MA, van Asselt ADI. Witlox WJA, et al. Among authors: grimm se. Pharmacoeconomics. 2021 Feb;39(2):171-180. doi: 10.1007/s40273-020-00971-x. Epub 2020 Nov 4. Pharmacoeconomics. 2021. PMID: 33145711 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters